Zydus Cadila

Pharmaceutical major Zydus Cadila on Monday received approval from Mexico’s Federal Commission for the Protection against Sanitary Risk (COFEPRIS) to test one of its lead research candidate Desidustat in the…

View Post

Latest News

Zydus Cadila Receives USFDA Nod To Market Generic Erlotinib Tablets

April 17, 2020 13:13
Healthwire Bureau

Drug firm Zydus Cadila on Friday said it has received final nod from the US health regulator to market generic Erlotinib tablets used for treatment of cancer. The company has…

View Post

Latest News

Zydus Cadila Receives Tentative Approval From The USFDA For Its Generic Version Carbidopa

March 30, 2020 15:43
Healthwire Bureau

Domestic pharma major Zydus Cadila, part of Cadila Healthcare group, on Monday said it has received tentative approval from the US health regulator for its generic version of Parkinson’s disease…

View Post

Menu

Zydus Cadila

Zydus Cadila Gets Approval From Mexican Authority COFEPRIS To Test COVID-19 Drug Desidustat

Zydus Cadila Receives USFDA Nod To Market Generic Erlotinib Tablets

Zydus Cadila Receives Tentative Approval From The USFDA For Its Generic Version Carbidopa

No MBBS Admissions Without Annual Declaration: NMC’s New Directive

High Court Slams Doctors for Prioritizing Private Practice Over Public Healthcare

National Cancer Awareness Day 2024: Fatigue, Unexplained Weight Loss, 6 Early Warning Signs of Cancer

Delhi AQI Today: Does Inhaling Toxic Smog Increases Heart Attack Risk?

Hearing Loss Is an Independent Risk Factor for Parkinson’s Disease: Jama Study Reveals

Breastfeeding Linked to Lower Rates of Postpartum Depression: Study Finds

Consuming High Levels of Omega-3, Omega-6 May Keep Cancer at Bay: Study Reveals

Effective Pain Management Approaches to Enhance Quality of Life